Literature DB >> 15234549

Leptin: linking adipocyte metabolism with cardiovascular and autoimmune diseases.

F Peelman1, W Waelput, H Iserentant, D Lavens, S Eyckerman, L Zabeau, J Tavernier.   

Abstract

Leptin was originally discovered as an adipocyte-derived hormone involved in the central control of body weight and energy homeostasis. It is now clear that leptin is a pleiotropic cytokine, with activities on many peripheral cell types. These findings may help explain the surprising role of leptin in pathophysiological processes. Recent evidence suggests that leptin contributes to atherosclerosis and to the increased risk of cardiovascular disease in obese people. Leptin also appears to be involved in T-cell-dependent immunity and possibly in the development and maintenance of certain autoimmune diseases. Here, we review the role of leptin in cardiovascular and autoimmune diseases, and also briefly address the potential therapeutic use of leptin antagonists.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15234549     DOI: 10.1016/j.plipres.2004.03.001

Source DB:  PubMed          Journal:  Prog Lipid Res        ISSN: 0163-7827            Impact factor:   16.195


  23 in total

Review 1.  Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus.

Authors:  Surapon Tangvarasittichai
Journal:  World J Diabetes       Date:  2015-04-15

2.  Prospective, randomized, single-blind comparison of effects of 6 months' treatment with atorvastatin versus pravastatin on leptin and angiogenic factors in patients with coronary artery disease.

Authors:  Yuji Takahashi; Mamoru Satoh; Tsuyoshi Tabuchi; Motoyuki Nakamura
Journal:  Heart Vessels       Date:  2011-06-04       Impact factor: 2.037

3.  Leptin and incident type 2 diabetes: risk or protection?

Authors:  M I Schmidt; B B Duncan; A Vigo; J S Pankow; D Couper; C M Ballantyne; R C Hoogeveen; G Heiss
Journal:  Diabetologia       Date:  2006-07-19       Impact factor: 10.122

Review 4.  The Role of Sleep Curtailment on Leptin Levels in Obesity and Diabetes Mellitus.

Authors:  Maryam Mosavat; Mitra Mirsanjari; Diana Arabiat; Aisling Smyth; Lisa Whitehead
Journal:  Obes Facts       Date:  2021-03-23       Impact factor: 3.942

Review 5.  Adipose tissue-mediated inflammation: the missing link between obesity and cardiovascular disease?

Authors:  Paolo Calabrò; Enrica Golia; Valeria Maddaloni; Marco Malvezzi; Beniamino Casillo; Carla Marotta; Raffaele Calabrò; Paolo Golino
Journal:  Intern Emerg Med       Date:  2008-12-04       Impact factor: 3.397

6.  The associations between serum leptin, adiponectin and intercellular adhesion molecule-1 in hypercholesterolemic patients.

Authors:  Eunju Park; Min-Jeong Shin; Namsik Chung
Journal:  Nutr Res Pract       Date:  2007-03-31       Impact factor: 1.926

Review 7.  Intra-abdominal adiposity, inflammation, and cardiovascular risk: new insight into global cardiometabolic risk.

Authors:  Paolo Calabro; Edward T H Yeh
Journal:  Curr Hypertens Rep       Date:  2008-02       Impact factor: 5.369

8.  Pegylated leptin antagonist is a potent orexigenic agent: preparation and mechanism of activity.

Authors:  Eran Elinav; Leonora Niv-Spector; Meirav Katz; Tulin O Price; Mohammed Ali; Michal Yacobovitz; Gili Solomon; Shay Reicher; Jessica L Lynch; Zamir Halpern; William A Banks; Arieh Gertler
Journal:  Endocrinology       Date:  2009-04-02       Impact factor: 4.736

Review 9.  The emerging role of leptin antagonist as potential therapeutic option for inflammatory bowel disease.

Authors:  Udai P Singh; Narendra P Singh; Hongbing Guan; Brandon Busbee; Robert L Price; Dennis D Taub; Manoj K Mishra; Raja Fayad; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  Int Rev Immunol       Date:  2013-07-10       Impact factor: 5.311

10.  The ambiguous role of the Na+-H+ exchanger isoform 1 (NHE1) in leptin-induced oxidative stress in human monocytes.

Authors:  Diamantis Konstantinidis; Konstantinos Paletas; George Koliakos; Martha Kaloyianni
Journal:  Cell Stress Chaperones       Date:  2009-03-20       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.